Coronary artery calcification, arterial stiffness and renal insufficiency associate with serum levels of tumor necrosis factor-alpha in Japanese type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages 58-65

  Hirota, Takuo ^a   Suzuki, Eiji ^a   Ito, Isamu ^a   Ishiyama, Masami ^a   Goto, Shinobu ^a   Horikawa, Yukio ^a   Asano, Takahiko ^a   Kanematsu, Masayuki ^a   Hoshi, Hiroaki ^a   Takeda, Jun ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial stiffness; Coronary artery calcification; Kidney disease; Tumor necrosis factor alpha; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALBUMINURIA; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; CALCINOSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52949140195     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.05.004     Document Type: Article

References (57)

1. Adler A.I., Stevens R.J., Manley S.E., Bilous R.W., Cull C.A., and Holman R.R. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS64). Kidney Int. 63 (2003) 225-232
2. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
3. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
4. So W.Y., Kong A.P., Ma R.C., Ozaki R., Szeto C.C., Chan N.N., et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 29 (2006) 2046-2052
5. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 31 (2008) S12-S54
6. Kramer H., and Molitch M.E. Screening for kidney disease in adults with diabetes. Diabetes Care 28 (2005) 1813-1816
7. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., and Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the Insulin Resistance Atherosclerosis Study. Kidney Int. 58 (2000) 1703-1710
8. Soinio M., Marniemi J., Laakso M., Lehto S., and Rönnemaa T. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care 29 (2006) 329-333
9. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
10. Egido J., Gómez-Chiarri M., Ortíz A., Bustos C., Alonso J., Gómez-Guerrero C., et al. Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int. Suppl. 39 (1993) S59-S64
11. Rus H.G., Niculescu F., and Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89 (1991) 247-254
12. Rashid G., Benchetrit S., Fishman D., and Bernheim J. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells. Kidney Int. 66 (2004) 1099-1106
13. Ruiz-Ortega M., Ruperez M., Lorenzo O., Esteban V., Blanco J., Mezzano S., et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int. Suppl. 82 (2002) 12-22
14. Jovinge S., Ares M.P., Kallin B., and Nilsson J. Human monocytes/macrophages release TNF-alpha in response to Ox-LDL. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 1573-1579
15. Chia S., Qadan M., Newton R., Ludlam C.A., Fox K.A., and Newby D.E. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 695-701
16. Hotamisligil G.S., and Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43 (1994) 1271-1278
17. Katsuki A., Sumida Y., Murashima S., Murata K., Takarada Y., Ito K., et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83 (1998) 859-862
18. Moriwaki Y., Yamamoto T., Shibutani Y., Aoki E., Tsutsumi Z., Takahashi S., et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52 (2003) 605-608
19. Mehrotra R., Budoff M., Hokanson J.E., Ipp E., Takasu J., and Adler S. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int. 68 (2005) 1258-1266
20. Smith A., Karalliedde J., De Angelis L., Goldsmith D., and Viberti G. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J. Am. Soc. Nephrol. 16 (2005) 1069-1075
21. Wexler L., Brundage B., Crouse J., Detrano R., Fuster V., Maddahi J., et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications, a statement for health professionals from the American Heart Association, Writing Group. Circulation 94 (1996) 1175-1192
22. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., and Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area, a histopathologic correlative study. Circulation 92 (1995) 2157-2162
23. Horiguchi J., Yamamoto H., Akiyama Y., Marukawa K., Hirai N., and Ito K. Coronary artery calcium scoring using 16-MDCT and a retrospective ECG-gating reconstruction algorithm. Am. J. Roentgenol. 183 (2004) 103-108
24. Hosoi M., Sato T., Yamagami K., Hasegawa T., Yamakita T., Miyamoto M., et al. Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients. Diabetes Care 25 (2002) 696-701
25. Schurgin S., Rich S., and Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 24 (2001) 335-338
26. Oxlund H., Rasmussen L.M., Andreassen T.T., and Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32 (1989) 748-752
27. Westerhof N., and O'Rourke M.F. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J. Hypertens. 13 (1995) 943-952
28. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., and Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 106 (2002) 2085-2090
29. Orchard T.J., and Strandness Jr. D.E. Assessment of peripheral vascular disease in diabetes, report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care 16 (1993) 1199-1209
30. Ravid M., Savin H., Jutrin I., Bental T., Katz B., and Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann. Intern. Med. 118 (1993) 577-581
31. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345 (2001) 861-869
32. Fliser D., Buchholz K., and Haller H. European trial on olmesartan and pravastatin in inflammation and atherosclerosis (EUTOPIA) investigators, antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110 (2004) 1103-1107
33. Ferro D., Parrotto S., Basili S., Alessandri C., and Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 36 (2000) 427-431
34. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 25 (2002) 359-364
35. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Hara S., et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin. Exp. Nephrol. 11 (2007) 41-50
36. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39 (2002) S46-S64
37. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
38. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15 (1990) 827-832
39. Janowitz W.R., Agatston A.S., Kaplan G., and Viamonte Jr. M. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am. J. Cardiol. 72 (1993) 247-254
40. Loria C.M., Liu K., Lewis C.E., Hulley S.B., Sidney S., Schreiner P.J., et al. Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J. Am. Coll. Cardiol. 49 (2007) 2013-2020
41. Wong T.Y., Cheung N., Islam F.M., Klein R., Criqui M.H., Cotch M.F., et al. Relation of retinopathy to coronary artery calcification: the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 167 (2008) 51-58
42. Blacher J., London G.M., Safar M.E., and Mourad J.J. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J. Hypertens. 17 (1999) 237-244
43. Liao D., Arnett D.K., Tyroler H.A., Riley W.A., Chambless L.E., Szklo M., et al. Arterial stiffness and the development of hypertension, The ARIC study. Hypertension 34 (1999) 201-206
44. Ogawa O., Hayashi C., Nakaniwa T., Tanaka Y., and Kawamori R. Arterial stiffness is associated with diabetic retinopathy in type 2 diabetes. Diabetes Res. Clin. Pract. 68 (2005) 162-166
45. Navarro J.F., Mora C., Rivero A., Gallego E., Chahin J., Macía M., et al. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration. Am. J. Kidney Dis. 33 (1999) 458-463
46. Sassy-Prigent C., Heudes D., Mandet C., Bélair M.F., Michel O., Perdereau B., et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49 (2000) 466-475
47. Stehouwer C.D., Gall M.A., Twisk J.W., Knudsen E., Emeis J.J., and Parving H.H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51 (2002) 1157-1165
48. Chen J., Muntner P., Hamm L.L., Fonseca V., Batuman V., Whelton P.K., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J. Am. Soc. Nephrol. 14 (2003) 469-477
49. Kramer H.J., Nguyen Q.D., Curhan G., and Hsu C.Y. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 289 (2003) 3273-3277
50. Rigalleau V., Lasseur C., Raffaitin C., Beauvieux M.C., Barthe N., Chauveau P., et al. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Diabetes Care 30 (2007) 2034-2039
51. Meigs J.B., Larson M.G., D'Agostino R.B., Levy D., Clouse M.E., Nathan D.M., et al. Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study. Diabetes Care 25 (2002) 1313-1319
52. Shioi A., Katagi M., Okuno Y., Mori K., Jono S., Koyama H., et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ. Res. 91 (2002) 9-16
53. Tintut Y., Patel J., Parhami F., and Demer L.L. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102 (2000) 2636-2642
54. Asmar R., Benetos A., Topouchian J., Laurent P., Pannier B., Brisac A.M., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement, validation and clinical application studies. Hypertension 26 (1995) 485-490
55. Picchi A., Gao X., Belmadani S., Potter B.J., Focardi M., Chilian W.M., et al. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 99 (2006) 69-77
56. Jovinge S., Hultgårdh-Nilsson A., Regnström J., and Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 490-497
57. Yamasaki Y., Kodama M., Nishizawa H., Sakamoto K., Matsuhisa M., Kajimoto Y., et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23 (2000) 1310-1315